Einstein in the Media | U.S./Global

Being diagnosed with prostate cancer can present many confusing choices about treatments and side effects. The New York Times reviews Dr. Arnold Melman’s new book,  After Prostate Cancer: A What-Comes-Next Guide to a Safe and Informed Recovery, noting its “straightforward and methodical” descriptions of treatments and side effects. Dr. Melman is professor and chair of urology at Einstein and Montefiore Medical Center. (Wednesday, August 31, 2011)

Dr. Melman's Profile
Good Housekeeping interviews Adam Friedman, M.D., about nutrients in food that slow the skin’s aging process and protect against UV damage, including vitamin C, lean protein, fatty fish and beta-carotene. Dr. Friedman is assistant professor of medicine and of physiology and biophysics. (Tuesday, August 30, 2011)

More coverage on Dr. Friedman | Dr. Friedman's Profile
Crain’s New York Business features Mark Mehler, M.D., in a series of profiles on neuroscientists working to unlock the mysteries of brain development, function and disease. Dr. Mehler is professor and chair of The Saul R. Korey Department of Neurology and director of Einstein’s Institute for Brain Disorders and Neural Regeneration. (Monday, August 22, 2011)

Dr. Mehler's Profile
The Los Angeles Times's "Booster Shots" blog features new research by Rajat Singh, M.D., M.B.B.S., that show dieting causes certain brain cells to start eating small portions of themselves — triggering a hunger response. Dr. Singh is assistant professor of medicine and of molecular pharmacology. (Wednesday, August 03, 2011)

More coverage on this story | Dr. Singh's Profile
NBC's The Today Show interviews Gil Atzmon, Ph.D., about the science of aging and whether measuring the length of a person's telomeres can be used to predict life span.  Dr. Atzmon notes that not enough research has been done on telomeres, so currently available consumer tests cannot provide accurate results. Dr. Atzmon is assistant professor of medicine and of genetics. (Wednesday, July 13, 2011)

More coverage on Dr. Atzmon | Dr. Atzmon's Profile
MSN (via Healthday) features new research by Eliseo Eugenin, Ph.D., that may explain why half of all HIV patients experience memory loss and other neurological problems, a condition known as NeuroAIDS, despite taking antiretroviral therapies. Dr. Eugenin’s study, published in the Journal of Neuroscience, indicates that a small group of supporting brain cells called astrocytes might be the key. In healthy people, these cells help maintain the blood-brain barrier, the network of blood vessels that protects the brain from harmful chemicals and toxins. The study suggests that when astrocytes are infected with HIV, it can lead to the brain being exposed to damaging toxins. Dr. Eugenin is assistant professor of pathology. (Wednesday, June 29, 2011)

Dr. Eugenin's Profile
CBS’ The Early Show interviews Sheryl Haut, M.D., about a patient at the Comprehensive Epilepsy Center of the Department of Neurology at Einstein and Montefiore Medical Center whose nocturnal seizures she successfully treated with surgery. The patient, Danny Jakubowitz, explains how drastically his life has improved since the surgery, which eliminated the seizures that robbed him of a full night’s sleep for 21 years. Dr. Haut is associate professor of clinical neurology in The Saul R. Korey Department of Neurology at Einstein and a neurologist specializing in adult care at Montefiore. (Thursday, June 23, 2011)

Dr. Haut's profile
The New York Daily News interviews Pamela Valera, Ph.D., M.S.W., about the Bronx Re-entry Working Group, a program created to help ex-convicts from the Bronx successfully transition back into society. Dr. Valera, who plans to survey the health behaviors of these ex-convicts next fall, notes that the program's major goal is to provide information and resources that could help paroled prisoners. Dr. Valera is an instructor of epidemiology & population health. (Tuesday, June 14, 2011)

Dr. Valera's Profile
The New York Times interviews Todd Feinberg, M.D., about conjoined twins joined at the head who seem to share sensory inputs and experiences. The twins brains are uniquely linked through the thalamus, an organ that filters most sensory input. Dr. Feinberg notes that their connection is unprecedented. Dr. Feinberg is professor of clinical psychiatry & behavioral sciences and of clinical neurology in The Saul R. Korey Department of Neurology. (Thursday, May 26, 2011)

More coverage on this story | Dr. Feinberg's Profile
WABC-TV interviews Amy Sanders, M.D., on a new study suggesting that learning music at an early age can significantly increase memory function later in life. The study compared the memories of musicians aged 45-65 who started playing at nine years of age and younger to non-musicians of the same ages and found an increase in cognitive processes. Dr. Sanders states that lifelong musical training helps keep the brain active, which helps maintain thinking ability as one ages. Dr. Sanders is assistant professor in the Saul R. Korey Department of Neurology. (Thursday, May 12, 2011)

Dr. Sander's Profile
The Wall Street Journal profiles critical care medicine at Montefiore Medical Center, the University Hospital and Academic Medical Center for Einstein. Vladimir Kvetan, M.D., director of critical care medicine at Montefiore, is credited with introducing numerous innovations to the hospital system that have improved care and efficiency while reducing mortality and cost. The article notes that Einstein has one of the nation’s largest training programs for critical care specialists. More than 250 critical care attending physicians and ICU directors trained here. Dr. Kvetan is professor of clinical medicine, of anesthesiology and of surgery at Einstein. (Monday, March 28, 2011)

Dr. Kvetan's profile
WCBS 880 interviews students and faculty for a story on Match Day, when fourth-year medical students learn where and in what specialty they will spend their next three to seven years of residency. Nadine Katz, M.D., noted that Einstein will have a high number of its graduating seniors going into primary care medicine – 43 percent, nearly 4 percent above the national average – which speaks to the commitment of Einstein students to serve their communities. Dr. Katz is senior associate dean for student academic affairs. (Friday, March 18, 2011)

More coverage on this story | More coverage on Dr. Katz | Dr. Katz's profile
NPR.com's Shots health blog interviews Chandan Guha, M.B.B.S., Ph.D., about the radiation exposure and health risks faced by the workers who remain at the disabled Fukushima Daiichi nuclear power plant in Japan. Those still onsite are fighting to prevent a meltdown and large amounts of radiation from leaking out. In light of the spiking levels of radiation detected outside the plant, Dr. Guha noted that the workers “are heroes.” Dr. Guha is professor and vice chair of radiation oncology at Einstein and Montefiore Medical Center. (Wednesday, March 16, 2011)

More coverage on this story | Dr. Guha's Profile
U.S. News & World Report (via HealthDay) features new research by Joanna Starrels, M.D., M.S., that found patients on painkillers, such as oxycodone, are frequently not closely monitored by the primary care doctors who prescribed the drugs. The study found that only 24 percent of those patients considered high-risk for drug abuse underwent drug testing and were more likely to get frequent refills than patients without a history of drug abuse. Dr. Starrels says the finding that doctors did not increase precautions for patients at highest risk for opioid misuse should bring attention to an important safety concern and be a call for a standardized approach to monitoring. Dr. Starrels is an assistant professor of medicine. (Thursday, March 10, 2011)

More coverage on this story | Dr. Starrels' Profile
Medscape Medical News profiles Susan Band Horwitz, Ph.D., who will receive the Eighth American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research on April 3. Dr. Horwitz identified the mechanism for action for the cancer chemotherapeutic drug Taxol, which has been used to treat over a million people with ovarian, breast or lung cancer. In addition to detailing her lab's Taxol discovery, Dr. Horwitz emphasizes the importance of mentoring young scientists, her concern that low NIH funding levels are discouraging to young scientists, and the need to maintain a sense of curiosity throughout one's career. Dr. Horwitz is the Rose C. Falkenstein Professor of Cancer Research and co-chair of molecular pharmacology at Einstein and associate director for experimental therapeutics at the Albert Einstein Cancer Center. (Free subscription required.) (Wednesday, February 23, 2011)

More coverage on this story | More coverage on Dr. Horwitz | Dr. Horwitz's profile
First Page | Previous Page | Page of 14 | Next Page | Last Page